Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Milrinone for LCOS Prevention in Infants
NCT03823781Phase 3Unknown
- Start
- Feb 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in low cardiac output syndrome (LCOS) comparing Milrinone Arm with Placebo Arm (2 arms). Primary endpoints: Number of participants died within 30 days postoperatively and Number of participants developed low cardiac output syndrome within the first 36 hours after initiation of study drug. Status: unknown.
02
Drugs
milrinone
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT03823781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03823781.